jueves, 13 de febrero de 2025

Cabozantinib Improves PFS in Advanced Neuroendocrine Tumors After Prior Treatment Edited by Katie Lennon February 13, 2025

Cabozantinib Improves PFS in Advanced Neuroendocrine Tumors After Prior Treatment Edited by Katie Lennon https://www.medscape.com/viewarticle/cabozantinib-improves-pfs-advanced-neuroendocrine-tumors-2025a10003s3 February 13, 2025

No hay comentarios:

Publicar un comentario